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In Reply to ‘The Myth of the Future Burden of CKD in United 
States’
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In our AJKD article, we reported estimates of the future prevalence of CKD using existing 
definitions of the disease.1 In their letter, Drs Delanaye, El Nahas, and Glassock state that 
the high prevalence of CKD in persons aged 65 and older is primarily due to aging and does 
not represent an added mortality risk.2 A few studies have indeed found that estimated GFR 
values between 45 and 59 mL/min/1.73 m2 are not associated with increased mortality.3 
However, other large epidemiologic studies have found that the relative and absolute risks of 
mortality are higher for the elderly with estimated GFR in this range than for the elderly 
with greater estimated GFR levels, even after controlling for albuminuria.4,5 Thus, we 
believe that CKD staging does provide prognostic information for persons aged 65 and 
older. We agree with Delanaye et al that not all persons who reach CKD stage 3a will 
progress to more advanced CKD stages; however, we disagree with their statement that 
“clearly stage 3a neither progresses to more severe stages nor shortens life expectancy” in 
persons aged 65 and older.
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